Article
Transduction of dendritic cells with recombinant adenovirus encoding HCA661 activates autologous cytotoxic T lymphocytes to target hepatoma cells.
British journal of cancer - 19 Apr 2004
Chan R C-F, Pang X-W, Wang Y-D, Chen W-F, Xie Y
Abstract excerpt
Transduction of recombinant adenovirus into dendritic cells (DCs) is a promising new tool for cancer vaccine development. Here, we report that an adenovirus vector carrying hepatocellular carcinoma (HCC) antigen HCA661 and infected into DCs generates T-cell immunity against hepatoma cells. HCA661 is a novel cancer/testis (CT) antigen screened by SEREX from sera of an HCC patient. We constructed a recombinant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
